Inicio › Enfermedad pulmonar intersticial › California › Los Angeles
Ensayos clínicos de Enfermedad pulmonar intersticial en Los Angeles, CA
14 estudios para Enfermedad pulmonar intersticial buscan participantes en centros de Los Angeles y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
ReclutandoFase 3
- University of Southern California, Los Angeles
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
ReclutandoFase 3
- University of California Los Angeles, Los Angeles
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoFase 3
- USA010, Los Angeles
- USA023, Los Angeles
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
ReclutandoFase 3
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
ReclutandoFase 3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
ReclutandoFase 2/3
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
ReclutandoFase 2
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
ReclutandoFase 3
- David Geffen School of Medicine at UCLA, Los Angeles
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoEstudio observacional
- Cedars-Sinai Medical Center, Los Angeles
Platform Clinical Study for Conquering Scleroderma
ReclutandoFase 2
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
ReclutandoEstudio observacional
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
ReclutandoFase 3
- Peter Morton Medical Building, Los Angeles
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
ReclutandoFase 2
- Keck School of Medicine of USC, Los Angeles
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
ReclutandoFase 2
- aTyr Investigative Site, Los Angeles
Más información sobre Enfermedad pulmonar intersticial en MedlinePlus
Ensayos de Enfermedad pulmonar intersticial en otras ciudades
- New York City, NY18 estudios
- Philadelphia, PA16 estudios
- Charleston, SC13 estudios
- Kansas City, KS13 estudios
- Durham, NC13 estudios
- Chicago, IL12 estudios
- Houston, TX12 estudios
- Aurora, CO11 estudios
- Ann Arbor, MI11 estudios
- Salt Lake City, UT9 estudios
- Dallas, TX9 estudios
- Boston, MA9 estudios
Otros estudios en Los Angeles
- Cáncer de pulmón de células no pequeñas87 estudios
- Cáncer (todos los tipos)74 estudios
- Cáncer de seno73 estudios
- Cáncer de próstata61 estudios
- Cáncer del colon y del recto59 estudios
- Cáncer metastásico57 estudios
- Cáncer de ovario50 estudios
- Cáncer de pulmón45 estudios
- Carcinoma de células escamosas de cabeza y cuello42 estudios
- Cáncer de páncreas35 estudios
- Cáncer de endometrio34 estudios
- Melanoma34 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.